Roberto Rodriguez, MD, is board-certified in medical oncology and practices hematology and oncology at Kaiser Permanente Los Angeles Medical Center.
Dr. Rodriguez is a National Cancer Institute community oncology program sub-investigator and participates in cancer research as a member of SWOG Cancer Research Network, National Surgical Adjuvant Bowel Project, NRG Oncology, and Alliance for Clinical Trials in Oncology.
As a member of the Southern California Regional Subspecialty Malignant Hematology Committee, Dr. Rodriguez has collaborated on data analysis of emerging therapeutics, which has been incorporated into the National Kaiser Permanente Oncology Care Pathways.
Dr. Rodriguez’s practice consists primarily of malignant hematology, and he provides regional expertise to the multidisciplinary Malignant Hematology Tumor Board.